Mediphage Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 17

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 11

Mediphage General Information

Description

Developer of a non-viral genetic medicine platform designed to improve the safety and quality of gene therapies. The company offers a high-fidelity linear DNA platform with reduced immunogenicity, durable gene expression, and versatile applications, enabling gene therapy developers and biotechnology companies to create safer, more reliable genetic medicines.

Contact Information

Website
www.mediphage.ca
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 661 University Avenue
  • Suite 1300, MaRS West Tower
  • Toronto, Ontario M5G 0B7
  • Canada
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
HealthTech, Life Sciences
Corporate Office
  • 661 University Avenue
  • Suite 1300, MaRS West Tower
  • Toronto, Ontario M5G 0B7
  • Canada

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Mediphage Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
12. Secondary Transaction - Private 01-Jan-2025 Completed Pre-Clinical Trials
11. Accelerator/Incubator 01-Jan-2025 Completed Pre-Clinical Trials
10. Seed Round 08-Feb-2024 Completed Pre-Clinical Trials
9. Accelerator/Incubator 01-Jan-2023 Completed Pre-Clinical Trials
8. Seed Round 16-Dec-2021 Completed Pre-Clinical Trials
7. Accelerator/Incubator 15-Jun-2020 Completed Pre-Clinical Trials
6. Grant 03-Jun-2020 Completed Pre-Clinical Trials
5. Accelerator/Incubator 03-Apr-2019 Completed Pre-Clinical Trials
4. Accelerator/Incubator 26-Apr-2018 $646K Completed Pre-Clinical Trials
3. Accelerator/Incubator 01-Mar-2018 $646K $646K Completed Pre-Clinical Trials
To view Mediphage’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Mediphage Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a non-viral genetic medicine platform designed to improve the safety and quality of gene therapies. The com
Drug Discovery
Toronto, Canada
17 As of 2024

Hampton, United Kingdom
 

Cambridge, United Kingdom
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Mediphage Competitors (2)

One of Mediphage’s 2 competitors is Touchlight, a Venture Capital-Backed company based in Hampton, United Kingdom.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Touchlight Venture Capital-Backed Hampton, United Kingdom
4basebio Corporation Cambridge, United Kingdom
You’re viewing 2 of 2 competitors. Get the full list »

Mediphage Patents

  • 25

    Total Documents Applications and Grants

  • Total Patents Families

  • 5

    Granted

  • 14

    Pending

  • Expiring in next 12 mo

Mediphage Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2023375259-A1 Ministring dna for producing adeno-associated virus Pending 02-Nov-2022
EP-4612307-A1 Ministring dna for producing adeno-associated virus Pending 02-Nov-2022
US-20260167988-A1 Ministring dna for producing adeno-associated virus Pending 02-Nov-2022
WO-2024095209-A1 Ministring dna for producing adeno-associated virus Inactive 02-Nov-2022
JP-2025538964-A Ministring dna for producing adeno-associated viruses Pending 02-Nov-2022 C12N15/86
To view Mediphage’s complete patent history, request access »

Mediphage Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Mediphage Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
Federal Economic Development Agency for Southern Ontario Government Minority
Ontario Genomics Accelerator/Incubator Minority
BioMedPartners Venture Capital Minority
Riverine Ventures Venture Capital Minority
Termeer Institute Accelerator/Incubator
You’re viewing 5 of 11 investors. Get the full list »

Ready to get started?

Request a free trial

Mediphage FAQs

  • When was Mediphage founded?

    Mediphage was founded in 2016.

  • Where is Mediphage headquartered?

    Mediphage is headquartered in Toronto, Canada.

  • What is the size of Mediphage?

    Mediphage has 17 total employees.

  • What industry is Mediphage in?

    Mediphage’s primary industry is Drug Discovery.

  • Is Mediphage a private or public company?

    Mediphage is a Private company.

  • What is Mediphage’s current revenue?

    The current revenue for Mediphage is .

  • How much funding has Mediphage raised over time?

    Mediphage has raised $4.11M.

  • Who are Mediphage’s investors?

    Federal Economic Development Agency for Southern Ontario, Ontario Genomics, BioMedPartners, Riverine Ventures, and Termeer Institute are 5 of 11 investors who have invested in Mediphage.

  • Who are Mediphage’s competitors?

    Touchlight and 4basebio are competitors of Mediphage.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process